OBJECTIVE Posterior fossa decompression with duraplasty (PFDD) is often used for Chiari
malformation type I (CM-I), but outcomes associated with different dural graft materials are …

In anticipation of the “Chiari and Syringomyelia Consensus Conference” held in Milan in
2019, we performed a systematic literature review on the management of Chiari …

Background Chiari malformation type 1 (CM1) is a rare condition where agreed
classification and treatment are still missing. The goal of this study is to achieve a consensus …

OBJECTIVE Posterior fossa decompression with duraplasty (PFDD) is commonly performed
for Chiari I malformation (CM-I) with syringomyelia (SM). However, complication rates …

OBJECTIVE Factors associated with syrinx size in pediatric patients undergoing posterior
fossa decompression (PFD) or PFD with duraplasty (PFDD) for Chiari malformation type I …

The preferred treatment of patients with persistent, recurrent, or progressive syringomyelia
after foramen magnum decompression (FMD) for Chiari I (CMI)-associated syringomyelia is …

OBJECTIVE When indicated, patients with symptomatic Chiari malformation type I (CM-I)
may benefit from suboccipital decompression (SOD). Although SOD is considered a lower …

Objective The role of atlantoaxial instability in the pathogenesis of Chiari 1 formation (Chiari
formation) in pediatric age-group patients is evaluated. Material and Methods During the …

Purpose Despite decades of experience and research, the etiology and management of
Chiari I malformations (CM-I) continue to raise more questions than answers. Controversy …

Background Chiari I malformations are common in adults and a frequent procedure in
neurosurgical practice. Despite several studies, there is no consensus about the indications …